Travere Therapeutics, Sony And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session

Benzinga_recent_news01-13

U.S. stock futures were lower this morning, with the Dow futures falling around 0.2% on Tuesday. Shares of Travere Therapeutics Inc (NASDAQ:TVTX) fell sharply in pre-market trading after the company ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2603268477?lang=en_US&edition=fundamental","thumbnail":"https://cdn.benzinga.com/files/images/story/2026/01/13/Display-Of-Stock-Market-Quotes.jpeg?optimize=medium&dpr=2&auto=webp&width=240","is_english":true,"pubTime":"2026-01-13 21:04","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2603268477","market":"sh","top_or_hot":-1,"title":"Travere Therapeutics, Sony And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session","media":"Benzinga_recent_news","content":"<div>\n<p>U.S. stock futures were lower this morning, with the Dow futures falling around 0.2% on Tuesday.\nShares of Travere Therapeutics Inc (NASDAQ:TVTX) fell sharply in pre-market trading after the company ...</p>\n\n<a href=\"https://www.benzinga.com/trading-ideas/movers/26/01/49871202/travere-therapeutics-sony-and-other-big-stocks-moving-lower-in-tuesdays-pre-market-session\">Source Link</a>\n\n</div>\n","source":"benzinga_recent_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Travere Therapeutics, Sony And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTravere Therapeutics, Sony And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-01-13 21:04 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.benzinga.com/trading-ideas/movers/26/01/49871202/travere-therapeutics-sony-and-other-big-stocks-moving-lower-in-tuesdays-pre-market-session><strong>Benzinga_recent_news</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>U.S. stock futures were lower this morning, with the Dow futures falling around 0.2% on Tuesday.\nShares of Travere Therapeutics Inc (NASDAQ:TVTX) fell sharply in pre-market trading after the company ...</p>\n\n<a href=\"https://www.benzinga.com/trading-ideas/movers/26/01/49871202/travere-therapeutics-sony-and-other-big-stocks-moving-lower-in-tuesdays-pre-market-session\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"TVTX","symbol_name":"Travere Therapeutics, Inc.","start_time":0,"source_url":"https://www.benzinga.com/trading-ideas/movers/26/01/49871202/travere-therapeutics-sony-and-other-big-stocks-moving-lower-in-tuesdays-pre-market-session","article_id":"2603268477","we_media_id":null,"thumbnails":["https://cdn.benzinga.com/files/images/story/2026/01/13/Display-Of-Stock-Market-Quotes.jpeg?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/trading-ideas/movers/26/01/49871202/travere-therapeutics-sony-and-other-big-stocks-moving-lower-in-tuesdays-pre-market-session","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2603268477","pubTimestamp":1768309440,"columns":[],"sourceInfo":{"source_id":"benzinga_recent_news","name":"Benzinga"},"weMediaInfo":null,"summary":"U.S. stock futures were lower this morning, with the Dow futures falling around 0.2% on Tuesday.Shares of Travere Therapeutics Inc  fell sharply in pre-market trading after the company issued a corporate update and 2026 outlook.Travere Therapeutics said it expects total U.S. net product sales for the fourth quarter to be $127 million and expects $410 million U.S. net product sales for 2025. The company said it will restart Phase 3 HARMONY study in the first quarter of 2026.Travere Therapeutics shares dipped 28.2% to $24.50 in pre-market trading.Here are some other stocks moving lower in pre-market trading.","collect":0,"end_time":0,"defaultTopTitle":"benzinga.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"TVTX":"Travere Therapeutics, Inc.","BK4571":"数字音乐概念","BK4588":"碎股","BK4539":"次新股","BK4585":"ETF&股票定投概念","LENZ":"Therapeutics","SONY":"索尼","LU0154236417.USD":"BGF US FLEXIBLE EQUITY \"A2\" ACC","BK4604":"机器人概念","BK4139":"生物科技","BK4554":"元宇宙及AR概念","BK4078":"消费电子产品","BK4577":"网络游戏","BK4007":"制药"},"translate_title":"Travere Therapeutics、索尼和其他大型股票在周二盘前交易中走低","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"TVTX":1,"LENZ":1.5,"SONY":1.5},"content_text":"U.S. stock futures were lower this morning, with the Dow futures falling around 0.2% on Tuesday.\nShares of Travere Therapeutics Inc (NASDAQ:TVTX) fell sharply in pre-market trading after the company issued a corporate update and 2026 outlook.\nTravere Therapeutics said it expects total U.S. net product sales for the fourth quarter to be $127 million and expects $410 million U.S. net product sales for 2025. The company said it will restart Phase 3 HARMONY study in the first quarter of 2026.\nTravere Therapeutics shares dipped 28.2% to $24.50 in pre-market trading.\nHere are some other stocks moving lower in pre-market trading.\nNow Read This: \nPhoto via Shutterstock","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2603268477","isCrawlerRequest":true}